Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Frequently asked questions
What sector does Profound Medical Corp (PROF) operate in?
Profound Medical Corp belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Profound Medical Corp (PROF) current stock price?
As of the latest data, Profound Medical Corp stock price is $5.55, with a previous close of $5.56. Profound Medical Corp lost -$0.01 in the last trading session, representing a -0.18% loss.
What is Profound Medical Corp (PROF) current market capitalization?
Profound Medical Corp market cap is approximately 202.80 million.
What is Profound Medical Corp (PROF) Earnings Per Share (EPS)?
The trailing EPS is -$1.20, and the forward EPS is -$0.59.
What is Profound Medical Corp (PROF) EBITDA?
Profound Medical Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -9.35 million.
Does Profound Medical Corp (PROF) pay dividends?
No. Profound Medical Corp does not pay a dividend.
How did Profound Medical Corp (PROF) perform in its most recent earnings report?
In the last report (June 30, 2026), Profound Medical Corp posted an EPS surprise of 218.18% and a revenue surprise of -62.5%.
When is Profound Medical Corp (PROF) next earnings report?
Profound Medical Corp is expected to release its next earnings report on September 30, 2026.
What is Profound Medical Corp (PROF) beta (volatility) score?
Profound Medical Corp has a beta of 0.555, indicating lower volatility than the overall market.
